Unity Biotechnology, Inc. (9U90.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:01AM CEST. Market open.
| Previous close | 1.2620 |
| Open | 1.2660 |
| Bid | 1.2660 x N/A |
| Ask | 1.3180 x N/A |
| Day's range | 1.2660 - 1.2660 |
| 52-week range | 1.1480 - 3.7900 |
| Volume | |
| Avg. volume | 72 |
| Market cap | 18.153M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
All You Need to Know About UNITY Biotechnology (UBX) Rating Upgrade to Buy
UNITY Biotechnology (UBX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- Insider Monkey
10 Supplements for Longevity and Antiaging: Expert Recommendations
In this article, we are going to discuss the 10 Supplements for Longevity and Antiaging: Expert Recommendations. You can skip our detailed analysis and go directly to 5 Supplements for Longevity and Antiaging: Expert Recommendations. The anti-aging and longevity market is undergoing a fascinating transformation, driven by personalized approaches, cutting-edge science, and a growing emphasis on evidence-based […]
- Simply Wall St.
Companies Like Unity Biotechnology (NASDAQ:UBX) Could Be Quite Risky
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
© 2024 Yahoo. All rights reserved.